MENU

COCP Stock Cocrystal Pharma (COCP, $2.11) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 18, 2024

A.I.dvisor
at Tickeron.com
Loading...
COCP - Cocrystal Pharma
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $2.11
Daily change: +$0.13 (+6.57%)
Daily volume: 93.6K
Capitalization: $22.8M
Industry: Biotechnology
This is a Bullish indicator signaling COCP's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 52 similar cases where COCP's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

COCP in upward trend: price rose above 50-day moving average on December 16, 2024

COCP moved above its 50-day moving average on December 16, 2024 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where COCP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on COCP as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COCP just turned positive on December 18, 2024. Looking at past instances where COCP's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for COCP crossed bullishly above the 50-day moving average on December 18, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COCP advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COCP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COCP broke above its upper Bollinger Band on December 20, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COCP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.802) is normal, around the industry mean (14.511). P/E Ratio (0.000) is within average values for comparable stocks, (86.507). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.738). COCP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (254.314).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel medicines for use in the treatment of human viral diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
19805 North Creek Parkway
Phone
+1 877 262-7123
Employees
12
Web
https://www.cocrystalpharma.com